GST : 27AEUPJ3828B1ZE

Call us now

08045475302

Send Inquiry

Request To Call Back

Forxiga Dapagliflozina Tablet

Name: Forxiga Dapagliflozina Tablet
Brand: DATTATRAYA MEDICAL & GENERAL STORES
Price: 1040 INR
Availability: InStock

Price 1040 INR/ Strip

Get a Price/Quote

MOQ : 10 Strips

Forxiga Dapagliflozina Tablet Specification

Indication
Adjunct to diet and exercise in type 2 diabetes

Packaging Type
Blister pack strip

Salt Composition
Dapagliflozin

Life Span
24 months from manufacturing date

Dosage Form
Tablet

Pacakaging (Quantity Per Box)
28 or 56 tablets per box

Brand Name
Forxiga

Drug Type
Allopathic

Ingredients
Dapagliflozina

Physical Form
Tablet

Function
Oral anti-diabetic medication (SGLT2 inhibitor)

Recommended For
Type 2 Diabetes Mellitus

Dosage
As prescribed by physician, typically 5 mg or 10 mg once daily

Dosage Guidelines
Take orally with or without food, at the same time every day

Suitable For
Adults

Quantity
14 tablets per strip

Storage Instructions
Store below 30C, protect from moisture and light

Pregnancy Category
Not recommended

Contraindications
Renal impairment, hypersensitivity to dapagliflozin

Shape
Oval tablet

Side Effects
May include urinary tract infection, genital infection, increased urination

Approval
Approved by DCGI (India) and EMA

Strength
5 mg or 10 mg

Marketed By
AstraZeneca Pharma India Ltd

Administration Route
Oral

Color
Yellow film-coated

Prescription Required
Yes

Forxiga Dapagliflozina Tablet Trade Information

Minimum Order Quantity
10 Strips

Payment Terms
Cash Advance (CA)

Supply Ability
5000 Strips Per Month

Delivery Time
5-7 Days

Main Export Market(s)
Asia, Australia, Central America, North America, South America, Eastern Europe, Western Europe, Middle East, Africa

About Forxiga Dapagliflozina Tablet

Buy Forxiga Dapagliflozina Tablet for your patients' type 2 diabetes management. Select strengths of 5 mg or 10 mg in preeminent yellow, oval, film-coated tablets for oral administration. Favored for its invincible role as an adjunct to diet and exercise, Forxiga-marketed by AstraZeneca Pharma India Ltd-has garnered blue-ribbon favorable reviews globally. Approved by DCGI (India) and EMA, each blister strip contains 14 allopathic tablets. Prescription required. Dosage and suitability determined by a physician. Not recommended during pregnancy; consult for contraindications and side effects.

Suitable Usage and Wide Applications of Forxiga Dapagliflozina Tablet

Forxiga Dapagliflozina Tablet is suitable for adult patients managing type 2 diabetes mellitus, as recommended by healthcare professionals. This blue-ribbon oral anti-diabetic is utilized commercially by exporters, suppliers, and traders across India for its efficacy as an SGLT2 inhibitor. Common applications include use in hospital and pharmacy settings, where the invincible Forxiga tablet forms a cornerstone in comprehensive diabetes care plans, used strictly as prescribed and as an adjunct to diet and exercise.

Main Export Markets, Supply Capacity, and Domestic Reach

The Forxiga Dapagliflozina Tablet boasts a robust rate of handover to both domestic and main export markets. AstraZeneca Pharma India ensures secure shipping and timely supply to meet expanding demand. With a supply ability to address large orders, this preeminent product is distributed widely throughout India and exported globally. Every transaction is backed by assurance of high-quality and safe delivery, making Forxiga a trusted choice for suppliers and healthcare professionals alike.

FAQ's of Forxiga Dapagliflozina Tablet:

Q: How should Forxiga Dapagliflozina Tablet be taken for optimal results?

A: Forxiga should be taken orally once daily, with or without food, at the same time each day. Always follow your physician's prescribed dosage, typically 5 mg or 10 mg per dose.

Q: What benefits does Forxiga offer in managing type 2 diabetes?

A: Forxiga is an SGLT2 inhibitor that helps lower blood sugar levels in adults with type 2 diabetes, serving as an adjunct to diet and exercise and receiving favorable reviews for improving glycemic control.

Q: When is Forxiga Dapagliflozina Tablet not recommended?

A: Forxiga is not recommended during pregnancy or for individuals with renal impairment or known hypersensitivity to dapagliflozin. Always consult your healthcare provider prior to use.

Q: Where is Forxiga approved and who markets it?

A: Forxiga is approved by the DCGI (India) and EMA. It is marketed by AstraZeneca Pharma India Ltd, ensuring international production and quality standards.

Q: What are the proper storage guidelines for Forxiga?

A: Store Forxiga tablets below 30C and protect them from moisture and light to preserve their efficacy and shelf life, which is 24 months from the manufacturing date.

Tell us about your requirement